NCT04399746View on ClinicalTrials.gov

Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

May 20, 2020

Study Completion Date

June 10, 2020

Conditions
COVID
Interventions
DRUG

Ivermectin

6mg once daily in day 0,1,7 and 8

DRUG

Azithromycin

500mg once daily for 4 days

DRUG

Cholecalciferol

400 IU twice daily for 30 days

Trial Locations (1)

14050

Outpatient treatment, Mexico City

All Listed Sponsors
lead

Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

OTHER_GOV

NCT04399746 - Ivermectin-Azithromycin-Cholecalciferol (IvAzCol) Combination Therapy for COVID-19 | Biotech Hunter | Biotech Hunter